About Company

SMIQ Pharma is INDIA Health Department approved major pharmaceutical company.

SMIQ Pharma is a Company that is managed by a group of vastly experienced professionals.

  • A Company that is a fully licensed, Health India approved, Speciality Medicine Company serving major markets across the world.
  • A thorough knowledge and understanding to manage every aspect of Pharmaceutical and Bio-Pharmaceutical shipments thus ensuring our systems uphold the highest standards to maintain and deliver the quality of all products.
  • SMIQ Pharma – India is a facilitator in importing Speciality Medicines pertaining to Cancer Care, Neurology etc.
  • We have offices and state of the art GMP compliant warehouses and depots in US, CANADA, UK, DUBAI and INDIA.

Our Core Values

  • Responsibility – Entrepreneurial actions is determined
  • Integrity – Ensures our Credibility
  • Transparency – Earning Trust

Our Vision

Transforming Lives Through Science and Innovation.

SMIQ Pharma’s vision is to be a global supplier of unmatched and highest quality speciality medicines providing the best client and patient experience. As an expert in global drug sourcing & supply, we are committed to provide cost advantages and stability of supply to our customers.

Our Team

aiyer

TRB Aiyer

Director – SMIQ Pharma

+91 9004695622 | trbaiyer1@gmail.com

TRB Aiyer comes with an enormous experience of nearly four decades in the fields of pharma care and oncology. His expertise predominantly lies in the realm of oncology, where he worked with leading doctors and clients for close to 20 years. He brings in high levels of business integrity and believes in driving business through ‘people development’. His strong communication and networking skills with stakeholders have helped him create many a win-win situation.

Before joining SMIQ Pharma, TRB headed the Oncology business unit at Merck (formerly known as E. Merck) as Associate Director. He holds a science degree and completed his MBA from Welingkar Institute of Management Development & Research.